Complete Pathologic Response After Concurrent Treatment with Pembrolizumab and Radiotherapy in Metastatic Colorectal Cancer: A Case Report

Due to specific genetic characteristics, therapeutic options for colorectal cancer (CRC) with DNA mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) are limited. Although programmed death 1 (PD-1) blockade has been shown to be highly effective therapy for dMMR/MSI-H CRC, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jian, Bi, Feng, Gou, Hongfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053529/
https://www.ncbi.nlm.nih.gov/pubmed/33880034
http://dx.doi.org/10.2147/OTT.S298333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053529/
https://www.ncbi.nlm.nih.gov/pubmed/33880034
http://dx.doi.org/10.2147/OTT.S298333

Ejemplares similares